Clinical trial
Evaluating the Efficacy of Nebulised 3% Hypertonic Saline for Acute Bronchiolitis in Infants: A Study at Can Tho Children's Hospital, 2022-2024
NCT06558461 is registered in ClinicalTrials.gov with Can Tho University of Medicine and Pharmacy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Efficacy of Nebulised 3% Hypertonic Saline for Acute Bronchiolitis in Infants: A Study at Can Tho Children's Hospital, 2022-2024
- Lead sponsor
- Can Tho University of Medicine and Pharmacy
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- May 28, 2024
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute bronchiolitis